Novo Nordisk A/S (B Shares) ADRhedged
NVOH
2 hedge funds and large institutions have $3.04K invested in Novo Nordisk A/S (B Shares) ADRhedged in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
1.57% less ownership
Funds ownership: 1.68% → 0.1% (-1.6%)
75% less capital invested
Capital invested by funds: $12.2K → $3.04K (-$9.21K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BL
BFSG LLC
Irvine,
California
|
+$634 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$8.05K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $2.44K | -$8.05K | -254 | -76% |
|
|
BL
2
BFSG LLC
Irvine,
California
| $602 | +$634 | +20 | New |
|
NVOH Hedge Fund Activity: Q3 2025 in Review
2 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk A/S (B Shares) ADRhedged (NVOH) for Q3 2025, worth a combined $3.04K — down 75% from $12.2K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new NVOH positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was BFSG LLC, opening a new position worth an estimated $634. The largest seller was UBS Group, cutting an estimated $8.05K.
- 2 institutional investors held Novo Nordisk A/S (B Shares) ADRhedged (NVOH) as of Q3 2025, up from 1 in Q2 2025.
- Funds reported $3.04K of Novo Nordisk A/S (B Shares) ADRhedged stock for Q3 2025, down 75% quarter-over-quarter.
- 1 fund opened new Novo Nordisk A/S (B Shares) ADRhedged positions in Q3 2025 and 0 closed out, a net change of +1 holder.
- The largest Novo Nordisk A/S (B Shares) ADRhedged buyer in Q3 2025 was BFSG LLC, an estimated $634 added.
- The largest Novo Nordisk A/S (B Shares) ADRhedged seller in Q3 2025 was UBS Group, an estimated $8.05K sold.
Based on aggregated 13F filings for Q3 2025.